Analyzing the suggested molecular networks of potential interaction partners of LRRC8A, previously known to be involved in the development of cancer (Figure S7) and cisplatin resistance (Figure S8), the Ingenuity Pathway Analysis software indicates that all subunits LRRC8B-E are suggested to be associated with cancer. Here, LRRC8A is linked to cancer.